Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOVER: IV Ibandronate vs Oral Risedronate in Osteoporosis
NCT00447915Phase 3Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Mar 2007
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibandronic acid in primary osteoporosis, sponsored by Chugai Pharmaceutical Co., Ltd.. Started Mar 2007; status: completed.
02
Drugs
ibandronic acid
03
Conditions
primary osteoporosis
Beyond the preview
Go deeper on NCT00447915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447915.